Emerging drugs for partial-onset epilepsy: a review of brivaracetam

There are more than 12 new antiepileptic drugs approved in the last 2 decades. Even with these newer agents, seizure remission is still unachievable in around 30% of patients with partial-onset seizures (POS). Brivaracetam (BRV) is chemically related to levetiracetam (LEV) and possesses a strong bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lan, Li, Shuchuen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863588/
https://www.ncbi.nlm.nih.gov/pubmed/27217762
http://dx.doi.org/10.2147/TCRM.S90127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863588/
https://www.ncbi.nlm.nih.gov/pubmed/27217762
http://dx.doi.org/10.2147/TCRM.S90127

Ejemplares similares